These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31256997)

  • 1. Mind the gap: Deficits in fundamental disease-specific knowledge in atrial fibrillation.
    LaRosa AR; Pusateri AM; Althouse AD; Mathier AS; Essien UR; Magnani JW
    Int J Cardiol; 2019 Oct; 292():272-276. PubMed ID: 31256997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the Atrial Fibrillation health Literacy Information Technology Trial: (AF-LITT).
    Guhl EN; Schlusser CL; Henault LE; Bickmore TW; Kimani E; Paasche-Orlow MK; Magnani JW
    Contemp Clin Trials; 2017 Nov; 62():153-158. PubMed ID: 28923492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.
    Rolls CA; Obamiro KO; Chalmers L; Bereznicki LRE
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28869793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.
    Obamiro KO; Chalmers L; Lee K; Bereznicki BJ; Bereznicki LRE
    Int J Clin Pract; 2018 Mar; 72(3):e13072. PubMed ID: 29457323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement.
    Frankel DS; Parker SE; Rosenfeld LE; Gorelick PB
    Heart Rhythm; 2015 Aug; 12(8):e105-13. PubMed ID: 25981149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation.
    Kapoor A; Amroze A; Vakil F; Crawford S; Der J; Mathew J; Alper E; Yogaratnam D; Javed S; Elhag R; Lin A; Narayanan S; Bartlett D; Nagy A; Shagoury BK; Fischer MA; Mazor KM; Saczynski JS; Ashburner JM; Lopes R; McManus DD
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005871. PubMed ID: 32063041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Cardiac Medications in Patients With Atrial Fibrillation: A Pilot Study.
    Pacleb A; Lowres N; Randall S; Neubeck L; Gallagher R
    Heart Lung Circ; 2020 Jul; 29(7):e131-e139. PubMed ID: 32089489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease.
    Tavassoli N; Perrin A; Bérard E; Gillette S; Vellas B; Rolland Y;
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):425-33. PubMed ID: 23943094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease understanding in patients newly diagnosed with atrial fibrillation.
    Kaufman BG; Kim S; Pieper K; Allen LA; Gersh BJ; Naccarelli GV; Ezekowitz MD; Fonarow GC; Mahaffey KW; Singer DE; Chan PS; Freeman JV; Ansell J; Kowey PR; Rieffel JA; Piccini J; Peterson E; O'Brien EC
    Heart; 2018 Mar; 104(6):494-501. PubMed ID: 28790169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.
    Kunneman M; Branda ME; Noseworthy PA; Linzer M; Burnett B; Dick S; Spencer-Bonilla G; Fernandez CA; Gorr H; Wambua M; Keune S; Zeballos-Palacios C; Hargraves I; Shah ND; Montori VM
    Trials; 2017 Sep; 18(1):443. PubMed ID: 28962662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.
    Ramakumar V; Benz AP; Karthikeyan G
    Indian Heart J; 2021; 73(2):244-248. PubMed ID: 33865530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.
    Zweiker D; Zweiker R; Winkler E; Roesch K; Schumacher M; Stepan V; Krippl P; Bauer N; Heine M; Reicht G; Zweiker G; Sprenger M; Watzinger N
    BMJ Open; 2017 Sep; 7(9):e018242. PubMed ID: 28951417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design.
    Baykaner T; Pundi K; Lin B; Lu Y; DeSutter K; Lhamo K; Garay G; Nunes JC; Morin DP; Sears SF; Chung MK; Paasche-Orlow MK; Sanders LM; Bunch TJ; Hills MT; Mahaffey KW; Stafford RS; Wang PJ
    Am Heart J; 2022 May; 247():68-75. PubMed ID: 35092723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    BMC Med Educ; 2016 Jan; 16():9. PubMed ID: 26758627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project.
    Lane DA; Ponsford J; Shelley A; Sirpal A; Lip GY
    Int J Cardiol; 2006 Jun; 110(3):354-8. PubMed ID: 16253356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Literacy and Awareness of Atrial Fibrillation.
    Reading SR; Go AS; Fang MC; Singer DE; Liu IA; Black MH; Udaltsova N; Reynolds K;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28400367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    J Clin Nurs; 2017 Dec; 26(23-24):4325-4334. PubMed ID: 28178370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.
    Hernández Madrid A; Potpara TS; Dagres N; Chen J; Larsen TB; Estner H; Todd D; Bongiorni MG; Sciaraffia E; Proclemer A; Cheggour S; Amara W; Blomstrom-Lundqvist C
    Europace; 2016 Mar; 18(3):463-7. PubMed ID: 26899998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.